ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)

National Institute of Allergy and Infectious Diseases (NIAID) · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
challenge
gastroenteritis norovirus, nov, cin-1, gii4. norovirus, challenge, fut-2 gene, hbga-blocking ab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 906957
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.